BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 28507177)

  • 1. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis.
    Chora I; Romano E; Manetti M; Mazzotta C; Costa R; Machado V; Cortez A; Bruni C; Lepri G; Guiducci S; De Paulis A; Soares R; Matucci-Cerinic M
    J Rheumatol; 2017 Aug; 44(8):1190-1197. PubMed ID: 28507177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells.
    Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.
    Romano E; Manetti M; Rosa I; Fioretto BS; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2018 Nov; 77(11):1665-1674. PubMed ID: 30021803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence.
    Manetti M; Romano E; Rosa I; Fioretto BS; Guiducci S; Bellando-Randone S; Pigatto E; Cozzi F; Ibba-Manneschi L; Matucci-Cerinic M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
    Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide.
    Borghini A; Manetti M; Nacci F; Bellando-Randone S; Guiducci S; Matucci-Cerinic M; Ibba-Manneschi L; Weber E
    PLoS One; 2015; 10(6):e0130166. PubMed ID: 26076019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
    D'Alessio S; Fibbi G; Cinelli M; Guiducci S; Del Rosso A; Margheri F; Serratì S; Pucci M; Kahaleh B; Fan P; Annunziato F; Cosmi L; Liotta F; Matucci-Cerinic M; Del Rosso M
    Arthritis Rheum; 2004 Oct; 50(10):3275-85. PubMed ID: 15476218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of junctional adhesion molecules in different stages of systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Rosa I; Ceccarelli C; Mello T; Milia AF; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Arthritis Rheum; 2013 Jan; 65(1):247-57. PubMed ID: 23001478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12.
    Margheri F; Serratì S; Lapucci A; Chillà A; Bazzichi L; Bombardieri S; Kahaleh B; Calorini L; Bianchini F; Fibbi G; Del Rosso M
    Arthritis Rheum; 2010 Aug; 62(8):2488-98. PubMed ID: 20506099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.
    Guiducci S; Manetti M; Romano E; Mazzanti B; Ceccarelli C; Dal Pozzo S; Milia AF; Bellando-Randone S; Fiori G; Conforti ML; Saccardi R; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2011 Nov; 70(11):2011-21. PubMed ID: 21821866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.
    Manetti M; Guiducci S; Romano E; Ceccarelli C; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Circ Res; 2011 Jul; 109(3):e14-26. PubMed ID: 21636803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor.
    Serratì S; Cinelli M; Margheri F; Guiducci S; Del Rosso A; Pucci M; Fibbi G; Bazzichi L; Bombardieri S; Matucci-Cerinic M; Del Rosso M
    J Pathol; 2006 Oct; 210(2):240-8. PubMed ID: 16917801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution to the peripheral vasculopathy and endothelial cell dysfunction by CXCL4 in Systemic Sclerosis.
    Jiang Z; Chen C; Yang S; He H; Zhu X; Liang M
    J Dermatol Sci; 2021 Oct; 104(1):63-73. PubMed ID: 34556381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease.
    Bielecki M; Kowal K; Lapinska A; Chwiesko-Minarowska S; Chyczewski L; Kowal-Bielecka O
    Adv Med Sci; 2011; 56(2):255-63. PubMed ID: 21983449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study.
    Romano E; Bellando-Randone S; Manetti M; Bruni C; Lepri G; Matucci-Cerinic M; Guiducci S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S148-52. PubMed ID: 26088817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
    Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
    Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells.
    Romano E; Rosa I; Fioretto BS; Giuggioli D; Manetti M; Matucci-Cerinic M
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI125-SI137. PubMed ID: 35900177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.